AbbVie Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was USD 28,121 million compared to USD 26,969 million a year ago. Net income was USD 5,414 million compared to USD 4,319 million a year ago. Diluted earnings per share from continuing operations was USD 3.03 compared to USD 2.41 a year ago.